| 05/15/2026 10:10 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Calidi Biotherapeutics (1855485) Subject | Form SCHEDULE 13G | |
| 05/14/2026 3:41 PM | Calidi Biotherapeutics (1855485) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2026 3:15 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2026 4:17 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 4:01 PM | Calidi Biotherapeutics (1855485) Filer | Form DEFA14A | |
| 04/29/2026 3:34 PM | Calidi Biotherapeutics (1855485) Filer | Form DEF 14A | |
| 04/17/2026 4:24 PM | Calidi Biotherapeutics (1855485) Filer | Form PRE 14A | |
| 04/02/2026 4:00 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:58 PM | Calidi Biotherapeutics (1855485) Subject Gavrilov Ognian Anguelov (2109116) Filed by | Form SCHEDULE 13D | |
| 03/27/2026 3:58 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 4:00 PM | Calidi Biotherapeutics (1855485) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CLDI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/09/2026 12:15 PM | Calidi Biotherapeutics (1855485) Subject Gavrilov Ognian Anguelov (2109116) Filed by | Form SCHEDULE 13D | |
| 03/06/2026 7:38 PM | Calidi Biotherapeutics (1855485) Filer | Form 424B5 | |
| 03/05/2026 8:59 PM | Calidi Biotherapeutics (1855485) Filer | Form S-3MEF | |
| 02/10/2026 1:08 PM | Calidi Biotherapeutics (1855485) Subject Lincoln Alternative Strategies LLC (2043812) Filed by | Form SCHEDULE 13G/A | |
| 02/04/2026 2:06 PM | Calidi Biotherapeutics (1855485) Subject Gavrilov Ognian Anguelov (2109116) Filed by | Form SCHEDULE 13G | |
| 12/16/2025 6:37 PM | Calidi Biotherapeutics (1855485) Issuer Camaisa Allan (1990674) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:46 PM | Calidi Biotherapeutics (1855485) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/10/2025 7:30 AM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/31/2025 3:15 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 4:16 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 4:00 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 6:56 PM | Calidi Biotherapeutics (1855485) Issuer Jackson Andrew C. (1636738) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/05/2025 6:56 PM | Calidi Biotherapeutics (1855485) Issuer Fernandez Santidrian Antonio (1990403) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/05/2025 6:56 PM | Calidi Biotherapeutics (1855485) Issuer Poma Eric E (1339484) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/29/2025 4:20 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2025 8:14 AM | Calidi Biotherapeutics (1855485) Issuer Lincoln Alternative Strategies LLC (2043812) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/27/2025 8:15 AM | Calidi Biotherapeutics (1855485) Subject Lincoln Alternative Strategies LLC (2043812) Filed by | Form SCHEDULE 13G | |
| 08/25/2025 7:47 PM | Calidi Biotherapeutics (1855485) Issuer Jackson Andrew C. (1636738) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 7:47 PM | Calidi Biotherapeutics (1855485) Issuer Leftwich Scott (1991668) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 7:47 PM | Calidi Biotherapeutics (1855485) Issuer Poma Eric E (1339484) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 7:47 PM | Calidi Biotherapeutics (1855485) Issuer Schoeneck James A (1420987) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/22/2025 4:27 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/21/2025 7:30 AM | Calidi Biotherapeutics (1855485) Filer | Form 424B4 | |
| 08/20/2025 11:16 PM | Calidi Biotherapeutics (1855485) Filer | Form EFFECT | |
| 08/15/2025 4:21 PM | Calidi Biotherapeutics (1855485) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 08/14/2025 8:05 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Calidi Biotherapeutics (1855485) Subject | Form SCHEDULE 13G/A | |
| 08/14/2025 4:18 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 3:35 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 3:46 PM | Calidi Biotherapeutics (1855485) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/25/2025 4:00 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad) When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days.
One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker. See the stock Musk's own words pointed to right here |
| 07/18/2025 4:17 PM | Calidi Biotherapeutics (1855485) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/15/2025 7:42 PM | Calidi Biotherapeutics (1855485) Issuer Leftwich Scott (1991668) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 7:42 PM | Calidi Biotherapeutics (1855485) Issuer Peoples George (2029803) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 7:42 PM | Calidi Biotherapeutics (1855485) Issuer Stewart Alan R. (1705492) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 7:42 PM | Calidi Biotherapeutics (1855485) Issuer Schoeneck James A (1420987) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/13/2025 11:15 PM | Calidi Biotherapeutics (1855485) Filer | Form EFFECT | |
| 07/11/2025 4:10 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2025 12:02 PM | Calidi Biotherapeutics (1855485) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2025 12:20 PM | Calidi Biotherapeutics (1855485) Filer | Form 424B3 | |
| 07/10/2025 12:20 PM | Calidi Biotherapeutics (1855485) Filer | Form 424B3 | |
| 07/03/2025 4:27 PM | Calidi Biotherapeutics (1855485) Filer | Form S-1 Registration statement under Securities Act of 1933 | |